Preliminary evaluation of the interactions of Panax ginseng and Salvia miltiorrhiza Bunge with 5-fluorouracil on pharmacokinetics in rats and pharmacodynamics in human cells

American Journal of Chinese Medicine

Volumn 41, Issue 2, 2013, Pages 443-458

  Gu, Chenxin ^a   Qiao, Jinping ^a   Zhu, Meilin ^a   Du, Jinglei ^a   Shang, Weihu ^a   Yin, Wei ^a   Wang, Wei ^a   Han, Mei ^a   Lu, Weidong ^b  

^a BEIJING NORMAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

5 Fluorouracil; Cytotoxicity; Panax ginseng (PGS); Pharmacodynamics; Pharmacokinetics; Salvia miltiorrhiza Bunge (SMB)

Indexed keywords

FLUOROURACIL; GINSENG EXTRACT; SALVIA MILTIORRHIZA EXTRACT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL ASSAY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG HALF LIFE; GINSENG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; RAT; SALVIA MILTIORRHIZA; STOMACH CANCER; WEIGHT REDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; DRUGS, CHINESE HERBAL; FLUOROURACIL; HUMANS; MALE; NEOPLASMS; PANAX; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA;

EID: 84876222590     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X13500328     Document Type: Article

References (46)

1. Bin, Y.S. and H. Kiat. Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid. Based Complement. Alternat. Med. 2011: 632829, 2011
2. Block, K.I. and M.N. Mead. Immune system effects of echinacea, ginseng, and astragalus: A review. Integr. Cancer Ther. 2: 247, 2003
3. Braz, A.D., M.D.F.M. Diniz and R.N. de Almeida. Recent advances in the use of Panax ginseng as an analgesic: A systematic review. Bol. Latinoam. Caribe Plantas M. 8: 188-194, 2009
4. Chan, S.E., H.W. Lai, C.C. Su, S.J. Kuo, S.Y. Chien, H.Y. Lin and D.R. Chen. Effect of supplementation of tanshinone IIA and sodium tanshinone IIA sulfonate on the anticancer effect of epirubicin: An in vitro study. Evid. Based Complement. Alternat. Med. 2011: 841564, 2011
5. Chavez, M.L., M.A. Jordan and P.I. Chavez. Evidence-based drug-herbal interactions. Life Sci. 78: 2146-2157, 2006
6. Cheng, R., L.A. Ridnour, S.A. Glynn, C.H. Switzer, W. Flores-Santana, P. Hussain, D.D. Thomas,S. Ambs, C.C. Harris and D.A. Wink. Nitric oxide and cancer: An overview. In: B. Bonavida (ed.) Nitric Oxide (NO) and Cancer. Humana Press, New York, 2010, pp. 3-20
7. Chow, L.W.C., W.T.Y. Loo and M.N.B. Cheung. The inhibitory effect of a herbal formula comprising ginseng and carthamus tinctorius on breast cancer. Life Sci. 76: 191-200, 2004
8. Corner, J., J. Yardley, E.J. Maher, L. Roffe, T. Young, S. Maslin-Prothero, C. Gwilliam, J. Haviland and G. Liwith. Patterns of complementary and alternative medicine use among patients undergoing cancer treatment. Eur. J. Cancer Care 18: 271-279, 2009
9. Delval, L. and J. Klastersky. Optic neuropathy in cancer patients. Report of a case possibly related to 5 fluorouracil toxicity and review of the literature. J. Neuro-Oncol. 60: 165-169, 2002
10. Ernst, E. Panax ginseng: An overview of the clinical evidence. J. Ginseng Res. 34: 259-263, 2010
11. Fishbein, A.B., C.Z. Wang, X.L. Li, S.R. Mehendale, S. Sun, H.H. Aung and C.S. Yuan. Asian ginseng enhances the anti-proliferative effect of 5-fluorouracil on human colorectal cancer: comparison between white and red ginseng. Arch. Pharm. Res. 32: 505-513, 2009
12. Gardiner, P., R. Graham, A.T. Legedza, A.C. Ahn, D.M. Eisenberg and R.S. Phillips. Factors associated with herbal therapy use by adults in the United States. Altern. Ther. Health Med. 13: 22-29, 2007
13. Hien, T.T., N.D. Kim, Y.R. Pokharel, S.J. Oh, M.Y. Lee and K.W. Kang. Ginsenoside Rg3 increases nitric oxide production via increases in phosphorylation and expression of endothelial nitric oxide synthase: essential roles of estrogen receptor-dependent PI3-kinase and AMP-activated protein kinase. Toxicol. Appl. Pharmacol. 246: 171-183, 2010
14. Hwang, J.W., J.H. Oh, H.S. Yoo, Y.W. Lee, C.K. Cho, K.R. Kwon, J.H. Yoon, J. Park, S. Her, Z.W. Lee, I.S. Jang and J.S. Choi. Mountain ginseng extract exhibits anti-lung cancer activity by inhibiting the nuclear translocation of NF-B. Am. J. Chin. Med. 40: 187-202, 2012
15. Jemal, A., F. Bray, M.M. Center, J. Ferlay, E. Ward and D. Forman. Global cancer statistics. CA-Cancer J. Clin. 61: 69-90, 2011
16. Li, X.L., C.Z. Wang, S.R. Mehendale, S. Sun, Q. Wang, and C.S. Yuan. Panaxadiol, a purified ginseng component, enhances the anti-cancer effects of 5-fluorouracil in human colorectal cancer cells. Cancer Chemother. Pharmacol. 64: 1097-1104, 2009
17. Malet-Martino, M. and R. Martino. Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine,UFT, S-1): A review. Oncologist 7: 288-323, 2002
18. Martinez, M.E., J.R. Marshall and E. Giovannucci. Diet and cancer prevention: The roles of observation and experimentation. Nat. Rev. Cancer 8: 694-703, 2008
19. Masini, E., F. Cianchi, R. Mastroianni and S. Cuzzocrea. Nitric oxide expression in cancer. In: B. Bonavida (ed.) Nitric Oxide (NO) and Cancer. Humana Press, New York, 2010, pp. 59-82
20. National Pharmacopoeia Committee. Part 1 (Herb medicine). In: National Pharmacopoeia Committee (ed.) Pharmacopoeia of People's Republic of China. Beijing Chemical Industry Press, Beijing,2005, pp. 7-53
21. Navolanic, P.M. and J.A. McCubrey. Pharmacological breast cancer therapy (review). Int. J. Oncol. 27: 1341-1344, 2005
22. Ng, T.B., F. Liu and Z.T. Wang. Antioxidative activity of natural products from plants. Life Sci. 66: 709-723, 2000
23. Peng, D.C. and J.T. Xie. Ginseng leaf-stem: bioactive constituents and pharmacological functions. Chin. Med. 20: 1-8, 2009
24. Rosecrans, R. and J.C. Dohnal. The effect of complimentary and alternative medicine products on laboratory testing. Semin. Diagn. Pathol. 26: 38-48, 2009
25. Sakaeda, T., M. Yamamori, A. Kuwahara and K. Nishiguchi. Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy. Adv. Drug Deliv. Rev. 61: 388-401, 2009
26. Sang, J., Y. Chen and Y. Tao. Nitric oxide inhibits gastric cancer cell growth through the modulation of the Akt pathway. Mol. Med. Rep. 4: 1163-1167, 2011
27. Saquib, J., C.L. Rock, L. Natarajan, N. Saquib, V.A. Newman, R.E. Patterson, C.A. Thomson, W.K. Al-Delaimy and J.P. Pierce. Dietary intake, supplement use, and survival among women diagnosed with early-stage breast cancer. Nutr. Cancer 63: 327-333, 2011
28. Schonekaes, K., R. Mucke, J. Panke, B. Rama and W. Wagner. Combined radiotherapy and temozolomide in patients with recurrent high grade glioma. Tumori 88: 28-31, 2002
29. Varjas, T., G. Nowrasteh, F. Budan, E. Nadasi, G. Horvath, S. Makai, T. Gracza, J. Cseh and I. Ember. Chemopreventive effect of Panax ginseng. Phytother. Res. 23: 1399-1403, 2009
30. Wang, B.X., J.C. Cui and A.J. Liu. The action of ginsenosides extracted from the stems and leaves of Panax Ginseng in promoting animal growth. Yao Xue Xue Bao 12: 899-904, 1982
31. Wang, J., S.S. Li, Y.Y. Fan, Y. Chen, D. Liu, H.R. Cheng, X.G. Gao and Y.F. Zhou. Anti-fatigue activity of the water-soluble polysaccharides isolated from Panax ginseng C. A. Meyer. J. Ethnopharmacol. 130: 421-423, 2010
32. Wang, C.Z., T. Calway and C.S. Yuan. Herbal medicines as adjuvants for cancer therapeutics. Am. J. Chin. Med. 40: 657-669, 2012
33. Wargovich, M.J., J. Morris, V. Brown, J. Ellis, B. Logothetis and R. Weber. Nutraceutical use in latestage cancer. Cancer Metastasis Rev. 29: 503-510, 2010
34. Wong, C.K., Y.X. Bao, E.L.Y. Wong, P.C. Leung, K.P. Fung and C.W.K. Lam. Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am. J. Chin. Med. 33: 381-395, 2005
35. Wong, V.K.W., S.S.F. Cheung, T. Li, Z.H. Jiang, J.R. Wang, H. Dong, X.Q. Yi, H. Zhou and L. Liu. Asian ginseng extract inhibits in vitro and in vivo growth of mouse lewis lung carcinoma via modulation of ERK-p53 and NF-kappa B signaling. J. Cell Biochem. 111: 899-910, 2010
36. Wu, H.Z., J. Qian and L.F. Zhan. Effect of nimesulide on pharmacokinetics of 5-fluorouracil in rats. J. Chin. Med. Univ. 35: 265-266, 2006
37. Xiong, J., M.J. Sun, J.X. Guo, L.S. Huang, S.J. Wang, B.Y. Meng and Q.N. Ping. Active absorption of ginsenoside Rg1 in vitro and in vivo: The role of sodium-dependent glucose co-transporter 1. J. Pharm. Pharmacol. 61: 381-386, 2009
38. Xu, Q.F., X.L. Fang and D.F. Chen. Pharmacokinetics and bioavailability of ginsenoside Rb-1 and Rg(1) from Panax notoginseng in rats. J. Ethnopharmacol. 84: 187-192, 2003
39. Yang, A.K., S.M. He, L. Liu, J.P. Liu, W.M. Qian and S.F. Zhou. Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr. Med. Chem. 17: 1635-1678, 2010
40. Ye, R.D., J.L. Han, X.W. Kong, L.Z. Zhao, R. Cao, Z.R. Rao and G. Zhao. Protective effects of ginsenoside Rd on PC12 cells against hydrogen peroxide. Biol. Pharm. Bull. 31: 1923-1927,2008
41. Yoon, Y., Y.O. Kim, W.K. Jeon, J.H. Park and H.J. Sung. Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. J. Ethnopharmacol. 68: 121-127, 1999
42. Yoshimura, K., N. Ueda, K. Ichioka, Y. Matsui, A. Terai and Y. Arai. Use of complementary and alternative medicine by patients with urologic cancer: A prospective study at a single Japanese institution. Support. Care Cancer 13: 685-690, 2005
43. Zhao, Y., Y.B. Hao, H.G. Ji, Y.Y. Fang, Y.H. Guo, W. Sha, Y.F. Zhou, X.W. Pang, W.M. Southerland, J.A. Califano and X.B. Gu. Combination effects of salvianolic acid B with lowdose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev. Res. 3: 787-796, 2010
44. Zhou, L.M., Z. Zuo and M.S.S. Chow. Danshen: An overview of its chemistry, pharmacology,pharmacokinetics, and clinical use. J. Clin. Pharmacol. 45: 1345-1359, 2005
45. Zhou, L.L., W.K. Chan, N.H. Xu, K. Xiao, H.W. Luo, K.Q. Luo and D.C. Chang. Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest. Life Sci. 83: 394-403, 2008
46. Zhou, X., J. Qiao, W. Yin, L. Zhu and H.F. Kung. Study the effect of a pseudo-carrier on pharmacokinetics of 9-fluoropropyl-(θ)- dihydrotetrabenazine in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 879: 505-510, 2011